Preview Mode Links will not work in preview mode

Eagle's Eye View: Your Weekly CV Update From

Sep 29, 2021

This week’s View focuses on the effect of neprilysin inhibition on BP in patients with HFpEF and resistant hypertension, three- vs. two-drug therapy for patients with newly diagnosed pulmonary artery hypertension, and early invasive angiography in acute HF.

Sep 22, 2021

This week's View summarizes articles on empagliflozin improving CV outcomes irrespective of blood pressure, the efficacy of the COVID-19 vaccine at 6 months post-vaccination, and the protection of the COVID-19 booster dose in Israel.

Sep 15, 2021

This week’s View summarizes articles about whether there are differences in daily symptom scores on statin, placebo, and no treatment in participants who had abandoned statins; the safety and immunogenicity of heterologous schedules with different coronavirus disease 2019 (COVID-19) vaccines; and the effectiveness of...

Sep 8, 2021

This week’s View summarizes articles about whether acute alcohol consumption increases the risk of a discrete atrial fibrillation (AF) episode, whether continuous cardiac rhythm monitoring beyond hospital discharge enhances AF detection among cardiac surgical patients, and if the addition of aspirin in fixed-dose...